Behrman acquires unit from Elan
US private equity house Behrman Capital has paid $122m for the lab testing services division of Irish pharmaceutical business Elan Corp.
US private equity house Behrman Capital has paid $122m for the lab testing services division of Irish pharmaceutical business Elan Corp.
Copyright PEI Media
Not for publication, email or dissemination